Innovative Ultrasound Technique Validated for Noninvasive Central Venous Pressure Measurement
A groundbreaking study validates a noninvasive ultrasound method to accurately measure central venous pressure, offering a safer alternative to invasive procedures and improving patient management in cardiovascular care.
A recent clinical pilot study has demonstrated the effectiveness of a novel noninvasive method to measure central venous pressure (CVP) using quantitative compression ultrasound (QCU). Conducted by researchers from the Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital (MGH), this advancement offers a promising alternative to traditional invasive techniques, which often involve risks and require significant resources.
The study enrolled 11 patients from MGH's cardiac intensive care unit, all with standard central venous catheters. Researchers captured QCU data, including high-resolution ultrasound images of the internal jugular vein (IJV), while simultaneously recording the force applied to the skin surface. These measurements were then compared to the gold-standard invasive CVP readings obtained directly from the catheters. In addition, jugular venous pulsation height (JVP), a common noninvasive clinical measurement, was assessed in some patients for comparison.
Results showed a strong correlation between the force needed to fully occlude the IJV, known as the collapse force (CF), and invasive CVP measurements. Statistical analysis revealed an r² value of 0.82, with a mean absolute error just over 1 mmHg. When accounting for hydrostatic pressure, the correlation slightly improved to 0.83. Conversely, JVP showed a weaker correlation with CVP, with an r² of 0.45.
The implications of these findings are significant for clinical practice. Accurate and noninvasive CVP assessment can enhance patient management in conditions like heart failure and sepsis, where CVP guides treatment decisions. Compared to invasive methods, QCU reduces risk, discomfort, and resource utilization, and surpasses traditional methods like JVP in reliability.
Led by experts from MIT and Harvard Medical School, including Alex T. Jaffe, Roger Pallarès-López, Jeffrey K. Raines, and Aaron D. Aguirre, this research paves the way for broader application of ultrasound technology in patient care. The study underscores the potential of QCU to transform circulatory assessment by enabling more frequent, safe, and precise monitoring, particularly in settings constrained by resources.
Source: https://medicalxpress.com/news/2025-05-noninvasive-ultrasound-method-central-venous.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Protecting Children from Heat-Related Illnesses as Temperatures Rise
As temperatures rise, understanding how to prevent heat-related illnesses in children is vital. Learn key signs, safety tips, and community strategies to protect young ones during hot weather.
Pre-Existing Immune Dysregulation as a Predictor of Severe Infection Outcomes
New research reveals that immune dysregulation before infection can predict the severity of disease responses. This discovery paves the way for personalized approaches to improving immune health and preventing severe illnesses.
Urinary Microbes and Their Role in Supporting Prostate Cancer Growth Through Hormone Alteration
Emerging research highlights how bacteria in the urinary tract can promote prostate cancer growth by converting steroids into androgens, revealing new avenues for hormonal cancer treatments.